Review began 09/05/2022 review ended 09/13/2022 published 09/19/2022 © copyright

HIGHLIGHTS

• who: Report and collaborators from the PAK Internal Medicine, Allama Iqbal Medical College, Lahore, PAK Internal Medicine, Dow University of Health have published the article: Review began 09/05/2022 Review ended 09/13/2022 Published 09/19/2022 u00a9 Copyright, in the Journal: (JOURNAL) of September/19,/2022
• what: Administration of a beta-blocker, such as propranolol, in a setting of TS, may result in thyrotoxic cardiomyopathy.
• future: A detailed analysis of such cardiovascular complications arising in thyrotoxicosis is required and more studies are needed to formulate a concrete therapeutic regimen for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.